HEK293FT Cells
| Unit |
3 x 10^6 cells/ml |
|---|---|
| Cell Type |
Immortalized Cells |
| Tissue Type |
Transformed cell lines |
| Organism |
Human |
| Donor History | |
| Growth Properties |
Adherent |
| Growth Conditions |
Culture medium: DMEM ,w: 4.5 g/L Glucose ,w: 4 mM L-Glutamine ,w: 3.7 g/L NaHCO3 ,w: 1.0 mM Sodium pyruvate (Cytion article number 820300a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Seeding density: 2 to 5 x 10⁴ cells/cm². Freeze medium: As a cryopreservation medium ,we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability ,or CM-1 (Cytion catalog number 800100) ,which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C ,5% CO2 ,humidified atmosphere. |
| Immortalization Method | |
| Full Information |
The HEK293FT cell line is a derivative of the HEK293 cell line, originally derived from human embryonic kidney cells. The “FT” designation indicates that these cells have been transfected with the SV40 large T-antigen gene, which enhances their ability to replicate plasmid vectors containing the SV40 origin of replication. This modification makes 293FT cells particularly useful for high-efficiency production of viral vectors, such as lentiviruses and adenoviruses, and for transfection studies in molecular biology and gene therapy research.
HEK293FT cells exhibit an epithelial morphology and grow rapidly in culture, providing a robust and reliable system for producing high-titer viral stocks. They retain many of the characteristics of the parental HEK293 cells, including high transfection efficiency and the ability to support the replication of recombinant viruses. Researchers utilize 293FT cells to produce viral vectors for gene delivery, to study gene function and regulation, and to develop gene therapies for various diseases. Their role in the production of viral vectors makes 293FT cells a cornerstone in the fields of gene therapy, functional genomics, and molecular cloning, facilitating the advancement of research and therapeutic development.
Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.
Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Čtečky identifikačních čipů
Termočipy
Biochemie
Imunoanalýza

